Lamond David 4
4 · Quince Therapeutics, Inc. · Filed Dec 14, 2023
Insider Transaction Report
Form 4
Lamond David
Director
Transactions
- Purchase
Common Stock
2023-12-13$1.00/sh+22,627$22,627→ 2,324,918 total(indirect: By Trust) - Purchase
Common Stock
2023-12-12$1.00/sh+300$300→ 2,279,964 total(indirect: By Trust) - Purchase
Common Stock
2023-12-12$1.02/sh+22,327$22,774→ 2,302,291 total - Purchase
Common Stock
2023-12-14$1.04/sh+22,627$23,532→ 2,347,545 total(indirect: By Trust)
Holdings
- 301,829
Common Stock
- 1,734,722(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.99 to $1.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.98 to $1.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]Mr. Lamond is the trustee of David A. Lamond Trust dated 2006 (the "2006 Trust") and holds sole voting and dispositive power with respect to the shares held of record by the 2006 Trust.